Product Description
CRISPR GENE DETECTION and DIAGNOSTIC MARKETS By Research, Clinical Lab, Consumer, Public Service & Other with Executive and Consultant Guides. 2022 to 2026
“CRISPR diagnosis and detection may become the primary use of this new technology. Diagnose your cold or flu or COVID from home. Simultaneous detection of multiple gene targets opens up new application for genetic information. Brings genetic identification into mainstream of society. Unlimited potential from a startling technology.”
CRISPR is not just about changing genes. CRISPR identifies unique genetic material instantly, accurately and cheaply. A whole new world of identification and diagnostics opens up. Instantly detect the presence of unwelcome bacteria, anywhere... And a new COVID test is already available.
Will this disruptive technology change the world of In Vitro Diagnostics forever? What is the impact on clinical laboratories? How will social norms be affected?
The market has just gotten started with a handful of small startup companies. Expect the big players to start taking notice. CRISPR is even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time.
The report forecasts the market size out to 2025. All report data is available in Excel format on request with the corporate license. Assistance and additional breakout data is available free of charge with the corporate license.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options, however your order is available as a credit if you wish to upgrade. We wrote this report and are ready by phone or email to help you use it.
Subscribe and Save
By signing up for the annual subscription, updates to this report will be automatically provided free of charge for a period of one year from initial purchase. These updates can include revised forecasts as markets increase or contract and exclusive market commentary not seen anywhere else. With the effects of COVID-19 being felt across all markets it has never been more crucial to stay fully informed with real-world actionable data. Subscribe to this report and receive ongoing market forecasting and analysis for sharpened strategic planning throughout the year.
Subscription deliverables:
- Quarterly report updates
- Summary of significant developments and market changes
- Phone consultation and assistance on request for the duration of the subscription
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School
